AMFPF
Price
$16.11
Change
-$2.22 (-12.11%)
Updated
Sep 25 closing price
Capitalization
3.61B
ARRJF
Price
$3.50
Change
+$0.43 (+14.01%)
Updated
Sep 25 closing price
Capitalization
927.23M
Interact to see
Advertisement

AMFPF vs ARRJF

Header iconAMFPF vs ARRJF Comparison
Open Charts AMFPF vs ARRJFBanner chart's image
Amplifon S.p.A
Price$16.11
Change-$2.22 (-12.11%)
Volume$397
Capitalization3.61B
Arjo AB
Price$3.50
Change+$0.43 (+14.01%)
Volume$100
Capitalization927.23M
AMFPF vs ARRJF Comparison Chart in %
Loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. ARRJF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and ARRJF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AMFPF: $16.11 vs. ARRJF: $3.50)
Brand notoriety: AMFPF and ARRJF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 3% vs. ARRJF: 2%
Market capitalization -- AMFPF: $3.61B vs. ARRJF: $927.23M
AMFPF [@Medical Distributors] is valued at $3.61B. ARRJF’s [@Medical Distributors] market capitalization is $927.23M. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 1 FA rating(s) are green whileARRJF’s FA Score has 1 green FA rating(s).

  • AMFPF’s FA Score: 1 green, 4 red.
  • ARRJF’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRJF is a better buy in the long-term than AMFPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 4 TA indicator(s) are bullish while ARRJF’s TA Score has 0 bullish TA indicator(s).

  • AMFPF’s TA Score: 4 bullish, 2 bearish.
  • ARRJF’s TA Score: 0 bullish, 1 bearish.
According to our system of comparison, AMFPF is a better buy in the short-term than ARRJF.

Price Growth

AMFPF (@Medical Distributors) experienced а -12.11% price change this week, while ARRJF (@Medical Distributors) price change was +14.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($3.61B) has a higher market cap than ARRJF($927M). AMFPF has higher P/E ratio than ARRJF: AMFPF (24.60) vs ARRJF (20.84). ARRJF YTD gains are higher at: 14.007 vs. AMFPF (-38.044). ARRJF has higher annual earnings (EBITDA): 1.97B vs. AMFPF (549M). ARRJF has more cash in the bank: 766M vs. AMFPF (243M). ARRJF has less debt than AMFPF: ARRJF (1.19B) vs AMFPF (1.83B). ARRJF has higher revenues than AMFPF: ARRJF (11.3B) vs AMFPF (2.41B).
AMFPFARRJFAMFPF / ARRJF
Capitalization3.61B927M390%
EBITDA549M1.97B28%
Gain YTD-38.04414.007-272%
P/E Ratio24.6020.84118%
Revenue2.41B11.3B21%
Total Cash243M766M32%
Total Debt1.83B1.19B154%
FUNDAMENTALS RATINGS
AMFPF vs ARRJF: Fundamental Ratings
AMFPF
ARRJF
OUTLOOK RATING
1..100
9946
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6584
PRICE GROWTH RATING
1..100
9047
P/E GROWTH RATING
1..100
8452
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (17) in the null industry is in the same range as AMFPF (26). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

ARRJF's Profit vs Risk Rating (100) in the null industry is in the same range as AMFPF (100). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

AMFPF's SMR Rating (65) in the null industry is in the same range as ARRJF (84). This means that AMFPF’s stock grew similarly to ARRJF’s over the last 12 months.

ARRJF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for AMFPF (90). This means that ARRJF’s stock grew somewhat faster than AMFPF’s over the last 12 months.

ARRJF's P/E Growth Rating (52) in the null industry is in the same range as AMFPF (84). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFARRJF
RSI
ODDS (%)
Bullish Trend 2 days ago
22%
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
26%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
19%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
28%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
13%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
5%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USXF56.710.36
+0.64%
iShares® ESG Advanced MSCI USA ETF
FEGE43.990.20
+0.46%
FIRST EAGLE GLOBAL EQUITY ETF
MDEV19.94N/A
N/A
First Trust Indxx Global Mdcl Dvcs ETF
UMAY35.73N/A
N/A
Innovator U.S. Equity Ultra BffrETF™-May
FCT9.98-0.01
-0.10%
First Trust Senior Floating Rate Income Fund II

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and COR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and COR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
COR - AMFPF
24%
Poorly correlated
+2.74%
ZYXI - AMFPF
7%
Poorly correlated
-1.36%
NSVGF - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
ARRJF - AMFPF
-0%
Poorly correlated
N/A
More

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and COSM have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
COSM - ARRJF
5%
Poorly correlated
-0.92%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
AMFPF - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More